Mediation of wound-related Rous sarcoma virus tumorigenesis by TFG (transforming growth factor)-. beta
- Univ. of California, Berkeley (USA)
- National Institutes of Health, Bethesda, MD (USA)
In Rous sarcoma virus (RSV)-infected chickens, wounding leads to tumor formation with nearly 100% frequency in tissues that would otherwise remain tumor-free. Identifying molecular mediators of this phenomenon should yield important clues to the mechanisms involved in RSV tumorigenesis. Immunohistochemical staining showed that TGF-{beta} is present locally shortly after wounding, but not in unwounded controls. In addition, subcutaneous administration of recombinant transforming growth factor {beta}1 (TGF-{beta}1) could substitute completely for wounding in tumor induction. A treatment protocol of four doses of 800 nanograms of TGF-{beta} resulted in v-src-expressing tumors with 100% frequency; four doses of only 10 nanograms still led to tumor formation in 80% of the animals. This effect was specific, as other growth factors with suggested roles in would healing did not elicit the same response. Epidermal growth factor (EGF) or TGF-{alpha} had no effect, and platelet-derived growth factor (PDGF) or insulin-like growth factor-1 (IGF-1) yielded only occasional tumors after longer latency. TGF-{beta} release during the would-healing response may thus be a critical event that creates a conducive environment for RSV tumorigenesis and may act as a cofactor for transformation in this system. 31 refs., 3 figs., 2 tabs.
- DOE Contract Number:
- AC03-76SF00098
- OSTI ID:
- 6509646
- Journal Information:
- Science (Washington, D.C.); (USA), Vol. 248:4963; ISSN 0036-8075
- Country of Publication:
- United States
- Language:
- English
Similar Records
Differential growth factor induction and modulation of human gastric epithelial regeneration
The role of the tetraspanin CD151 in primary keratinocyte and fibroblast functions: Implications for wound healing